TAIPEI, Taiwan and GROTON, Conn., Jan. 16, 2018 /PRNewswire/ — Lumosa Therapeutics (Lumosa, 6535.TWO), a new drug development company in Taiwan, and Skyline Vet Pharma (SVP), an emerging animal health company in the USA, today announced a licensing agreement for Lumosa’s CS011. According…
